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ABSTRACT
The coronavirus disease 2019 (COVID-19) affects billions of
lives around the world and has a significant impact on public
healthcare. Due to rising skepticism towards the sensitivity of
RT-PCR as screening method, medical imaging like computed
tomography  offers  great  potential  as  alternative.  For  this
reason,  automated  image  segmentation  is  highly  desired  as
clinical  decision  support  for  quantitative  assessment  and
disease  monitoring.  However,  publicly  available  COVID-19
imaging data is limited which leads to overfitting of traditional
approaches. To address this problem, we propose an innovative
automated  segmentation  pipeline  for  COVID-19  infected
regions, which is able to handle small datasets by utilization as
variant  databases.  Our  method  focuses  on  on-the-fly
generation of unique and random image patches for training
by performing several preprocessing methods and exploiting
extensive  data  augmentation.  For  further  reduction  of  the
overfitting  risk,  we  implemented  a  standard  3D  U-Net
architecture instead of new or computational complex neural
network architectures. Through a 5-fold cross-validation on 20
CT scans of  COVID-19 patients,  we were able  to develop a
highly accurate as well as robust segmentation model for lungs
and  COVID-19  infected  regions  without  overfitting  on  the
limited data. Our method achieved Dice similarity coefficients
of 0.956 for lungs and 0.761 for infection.  We demonstrated
that  the  proposed  method  outperforms  related  approaches,
advances the state-of-the-art for COVID-19 segmentation and
improves medical image analysis with limited data. The code
and model are available under the following link: 
https://github.com/frankkramer-lab/covid19.MIScnn
Keywords: COVID-19,  segmentation,  computed
tomography,  deep  learning,  artificial  intelligence,  clinical
decision support
1. INTRODUCTION
The  ongoing  coronavirus  pandemic  has  currently  (4th of
May 2020) spread to 187 countries in the world  [1]. The
World Health Organization (WHO) declared the outbreak as
a “Public Health Emergency of International Concern” on
the 30th of January 2020 and as a pandemic on the 11th of
March 2020  [2,3].  Because of the rapid spread of severe
respiratory syndrome coronavirus 2 (SARS-CoV-2), billions
of lives  around the world were changed.  A SARS-CoV-2
infection can lead to a severe pneumonia with potentially
fatal  outcome  [3–5].  Until  now,  there  are  3,531,618
confirmed cases in total resulting in 248,097 deaths [1]. So
far, there is neither an effective treatment for the infection,
nor  is  there  an  effective  prevention  against  it,  such  as  a
vaccination [3,4,6,7].  Additionally,  the  rapid  increase  of
confirmed  cases  and  the  resulting  estimated  basic
reproduction  numbers  show  that  SARS-CoV-2  is  highly
contagious [4,6,8]. Therefore, fast detection and isolation of
infected persons are crucial in order to limit the spread of
the virus.  The WHO named this new disease “coronavirus
disease 2019”, short form: COVID-19.
The  reverse  transcription  polymerase  chain
reaction (RT-PCR) was established as the standard approach
for COVID-19 screening  [2,4,6]. RT-PCR is able to detect
the  viral  RNA in  specimens  obtained  by  nasopharyngeal
swab,  oropharyngeal  swab,  bronchoalveolar  lavage  or
tracheal  aspirate  [2,4,6,7].  However,  a  variety  of  recent
studies  indicate  that  RT-PCR  testing  suffers  from  a  low
sensitivity,  approximately  around  71%,  whereby  repeated
testing is needed for accurate diagnosis [9,10]. Furthermore,
RT-PCR screening  is  time-consuming  and  has  increasing
availability limitations due to shortage of required material
[10]. 
An alternative solution to RT-PCR for COVID-19
screening  is  medical  imaging  like  X-ray  or  computed
tomography  (CT).  The  medical  imaging  technology  has
made  significant  progress  in  recent  years  and  is  now  a
commonly  used  method  for  diagnosis,  as  well  for
quantification  assessment  of  numerous  diseases  [11–13].
Particularly, chest CT screening has emerged as a routine
diagnostic tool for pneumonia. Therefore, chest CT imaging
has  also  been  strongly  recommended  for  COVID-19
diagnosis  and  follow-up  [9].  In  addition,  CT imaging  is
playing  an  important  role  in  COVID-19  quantification
assessment,  as  well  as  disease  monitoring.  COVID-19
infected areas are distinguishable on CT images by ground-
glass  opacity  (GGO)  in  the  early  infection  stage  and  by
pulmonary consolidation in the late infection stage [6,9,14].
In comparison to RT-PCR, several studies showed that CT
is  more  sensitive  and  effective  for  COVID-19 screening,
and that chest CT imaging is more sensitive for COVID-19
testing even without  the occurrence of  clinical  symptoms
[9,10,12,14].  Notably,  a  large  clinical  study  with  1,014
patients  in  Wuhan  (China)  determined  that  chest  CT
analysis  can achieve 0.97 sensitivity,  0.25 specificity and
0.68 accuracy for COVID-19 detection [9].
Still,  evaluation  of  medical  images  is  a  manual,
tedious  and  time-consuming  process  performed  by
radiologists. Even though increasing CT scan resolution and
number of slices resulted in higher sensitivity and accuracy,
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these  improvements  also  increased  the  workload.
Additionally,  annotations  of  medical  images  are  often
highly influenced by clinical experience [15,16]. 
A solution for  these challenges could  be clinical
decision  support  systems  based  on  automated  medical
image analysis.  In  recent  years,  artificial  intelligence  has
seen  a rapid growth with  deep  learning  models,  whereas
image segmentation is a popular sub-field  [11,17,18]. The
aim of medical image segmentation (MIS) is the automated
identification and labeling of regions of interest (ROI) e.g.
organs like lungs or medical abnormalities like cancer and
lesions.  In  recent  studies,  medical  image  segmentation
models  based  on  neural  networks  proved  powerful
prediction  capabilities  and  achieved  similar  results  as
radiologists regarding the performance [11,19]. It would be
a helpful tool to implement such an automatic segmentation
for COVID-19 infected regions as clinical decision support
for physicians. By automatic highlighting abnormal features
and ROIs, image segmentation is able to aid radiologists in
diagnosis,  disease  course  monitoring,  reduction  of  time-
consuming  inspection  processes  and  improvement  of
accuracy  [11,12,20].  Nevertheless,  training  accurate  and
robust models requires sufficient annotated medical imaging
data.  Because  manual  annotation  is  labor-intensive,  time-
consuming  and  requires  experienced  radiologists,  it  is
common that publicly available data is limited  [11,12,16].
This  lack  of  data  often  results  in  an  overfitting  of  the
traditional data-hungry models. Especially for COVID-19,
large  enough  medical  imaging  datasets  are  currently
unavailable [12,16].
In this work, we push towards creating an accurate
and  state-of-the-art  MIS  pipeline  for  COVID-19  lung
infection segmentation, which is capable of being trained on
small  datasets  consisting of  3D CT volumes.  In  order  to
avoid  overfitting,  we  exploit  extensive  on-the-fly  data
augmentation, as well as diverse preprocessing methods. In
order to further reduce the risk of overfitting, we implement
the  standard  U-Net  architecture  instead  of  other  more
computational  complex  variants,  like  the  residual
architecture  of  the  U-Net.  Furthermore,  we  use  a  5-fold
cross-validation for reliable performance evaluation.
2. RELATED WORK
Since  the  breakthrough  of  convolutional  neural  network
(CNN) architectures for computer vision, neural  networks
became  one  of  the  most  accurate  and  popular  machine
learning  algorithm for  automated  medical  image  analysis
[11,17,21].  Two  of  the  major  tasks  in  this  field  are
classification  and  segmentation.  Whereas  medical  image
classification aims to label a complete image to predefined
classes  (e.g.  to a  diagnosis),  medical  image segmentation
aims  to  label  each  pixel  in  order  to  identify  ROIs  (e.g.
organs  or  medical  abnormalities).  Popular  deep  learning
architectures,  which  achieved  performance  equivalent  to
humans, are Inception-v3, ResNet, as well as DenseNet for
classification and  VB-Net,  U-Net  and  various variants  of
the U-Net for segmentation [12,22–24].
In reaction to the rapid spread of the coronavirus,
many  scientists  quickly  reacted  and  developed  various
approaches  based  on  deep  learning  to  contribute  to  the
efforts  against  COVID-19.  Furthermore,  the  scientific
community  focused  their  efforts  on  the  development  of
models for COVID-19 classification, because x-ray and CT
images  of  infected  patients  could  be  collected  without
further  required  annotations  [12,20].  These  classification
algorithms can be categorized through their objectives: 1)
Classification of COVID-19 from non-COVID-19 (healthy)
patients, which resulted into models achieving a sensitivity
of 94.1%, specificity of 95.5%, and AUC of 0.979 (Jin et
al)  [25].  2)  Classification  of  COVID-19  from  other
pneumonia, which resulted in models achieving a sensitivity
of 90%, specificity of 96%, and AUC of 0.96 (Li et al) [26].
3) Severity assessment of COVID-19, which resulted in a
model achieving a true positive rate of 93.3%, true negative
rate of 74.5%, and accuracy of 87.5% (Tang et al.) [27].
In  the  last  weeks,  clinicians  started  to  publish
COVID-19 CT images with annotated ROIs, which allowed
the  training  of  segmentation  models.  Automated
segmentation  is  highly  desired  as  COVID-19  application
[12,28].  The  segmentation  of  lung,  lung  lobes  and  lung
infection  provides  accurate  quantification  data  for
progression  assessment  in  follow-up,  comprehensive
prediction of severity in the enrollment and visualization of
lesion distribution using percentage of infection (POI) [12].
Still, the limited amount of annotated imaging data causes a
challenging task for detecting the variety of shapes, textures
and  localizations  of  lesions  or  nodules.  Nonetheless,
multiple  approaches  try  to  solve  these  problems  with
different  methods.  The most  popular  network  models  for
COVID-19 segmentation are variants of the U-Net which
achieved reasonable performance on sufficiently sized 2D
datasets  [5,12,29–33].  In  order  to  compensate  limited
dataset  sizes,  more  attention  has  been  drawn  to  semi-
supervised  learning  pipelines  [12,34].  These  methods
optimize a supervised training on labeled data along with an
unsupervised training on unlabeled data. Another approach
is the development of special neural network architectures
Figure  1: Visualization of COVID-19 infected regions in a chest CT. The
left image is  the unsegmented CT scan, whereas the right image shows
segmentation of lungs (blue) and infection (red). The infected regions are
distinguishable by GGOs and pulmonary consolidation in the lung regions.
The image was obtained from the analyzed CT dataset [36].
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for  handling  limited  dataset  sizes.  Frequently,  attention
mechanism are built into the classic U-Net architecture like
the Inf-Net from Fan et al. [34] or the MiniSeg from Qiu et
al [35]. Particularly worth mentioning is the development of
a  benchmark  model  with  a  3D  U-Net  from  Ma  et  al,
because  the  authors  also  provide  high  reproducibility
through a publicly available dataset [16,36].
3. MATERIALS AND METHODS
The implemented medical image segmentation pipeline can
be summarized in the following core steps and is illustrated
in figure 2:
• Dataset: 20x COVID-19 CT volumes
• Limited dataset → Utilization as variation database
• Several preprocessing methods
• Extensive data augmentation
• Patchwise analysis of high-resolution images
• Utilization of the standard 3D U-Net
• Model fitting based on Tversky index & cross-entropy
• Model predictions on overlapping patches
• 5-fold cross-validation via Dice similarity coefficient
This pipeline was based on MIScnn  [37], which is an in-
house developed open-source framework to setup complete
medical  image  segmentation  pipelines  with  convolutional
neural  networks  and  deep  learning  models  on  top  of
Tensorflow/Keras  [38].  MIScnn  supports  extensive
preprocessing,  data  augmentation,  state-of-the-art  deep
learning models and diverse evaluation techniques.
3.1 Dataset of COVID-19 Chest CTs
In  this  study,  we used  the  public  dataset  from  Ma et  al.
which  consists  of  20  annotated  COVID-19  chest  CT
volumes [16,36]. At the time of this paper, this dataset is the
only  publicly  available  3D  volume  set  with  annotated
COVID-19 infection segmentation [16]. The CT scans were
collected from the Coronacases Initiative and Radiopaedia
and were licensed under CC BY-NC-SA. Each CT volume
was first labeled by junior annotators, then refined by two
radiologists with 5 years of experience and afterwards the
annotations verified by senior radiologists with more than
10 years of experience [16]. Despite the fact that the sample
size  is  rather  small,  the  annotation  process  led  to  an
excellent high-quality dataset. The volumes had a resolution
of  512x512  (Coronacases  Initiative)  or  630x630
(Radiopaedia)  with  a  number  of  slices  of  about  176  by
mean (200 by median). The CT images were labeled into
four classes: Background, lung left, lung right and COVID-
19 infection.
In  our  pipeline,  we  performed  a  5-fold  cross-
validation on the dataset.  This resulted in five fitting and
inference runs with each time 16 samples as training dataset
and 4 samples for prediction. We decided not to follow the
convention of splitting the dataset into training, validation
and testing sets due to the limited dataset size and because
we do not  configure  any hyper parameters  afterwards on
basis of validation/testing results.
3.2 Preprocessing
In order to simplify the pattern finding and fitting process
for the model, we applied several preprocessing methods on
the dataset.
We exploited the Hounsfield units (HU) scale by
clipping the pixel intensity values of the images to -1,250 as
minimum  and  +250  as  maximum,  because  we  were
interested in infected regions (+50 to +100 HU) and lung
regions (-1,000 to -700 HU). It was only possible to apply
the  clipping  approach  on  the  Coronacases  Initiative  CTs,
because the Radiopaedia volumes were already normalized
to a grayscale range between 0 and 255.
Varying  signal  intensity  ranges  of  images  can
drastically  influence  the  fitting  process  and  the  resulting
performance  of  segmentation  models  [39].  For  achieving
dynamic  signal  intensity  range  consistency,  it  is
recommended  to  scale  and  standardize  imaging  data.
Therefore,  we  normalized  the  Coronacases  Initiative CT
volumes  likewise  to  grayscale  range.  Afterwards,  all
samples were standardized via z-score.
Medical  imaging  volumes  have  commonly
inhomogeneous  voxel  spacings.  The  interpretation  of
diverse voxel spacings is a challenging task for deep neural
networks.  Therefore,  it  is  possible  to  drastically  reduce
complexity by resampling volumes in an imaging dataset to
homogeneous  voxel  spacing,  which  is  also  called  target
spacing. Resampling voxel spacings also directly resizes the
volume shape and determines  the contextual  information,
which the neural  network model  is  able to capture.  As a
result,  the  target  spacing  has  a  huge impact  on  the  final
model  performance.  We  decided  to  resample  all  CT
volumes to a target spacing of 1.58x1.58x2.70, resulting in
a median volume shape of 267x254x104.
Figure  2: Flowchart diagram of the implemented medical image analysis
pipeline  for  COVID-19  lung  infection  segmentation.  The  workflow  is
starting  with  the  COVID-19  dataset  and  ending  with  the  computed
evaluation results for each fold in the cross-validation.
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3.3 Data Augmentation
The  aim of  data  augmentation  is  to  create  more  data  of
reasonable  variations  of  the  desired  pattern  and,  thus,
artificially increase the number of training images. In order
to  compensate  the  small  dataset  size,  we  performed
extensive data augmentation by using the batchgenerators
interface within MIScnn. The batchgenerators package is an
API  for  state-of-the-art  data  augmentation  on  medical
images from the Division of Medical Image Computing at
the  German  Cancer  Research  Center  (DKFZ)  [40].  We
implemented  three  types  of  augmentations:  Spatial
augmentation by mirroring, elastic deformations, rotations
and  scaling.  Color  augmentations  by  brightness,  contrast
and  gamma  alterations.  Noise  augmentations  by  adding
Gaussian noise.  We performed the data augmentation on-
the-fly  on  each  image  before  it  was  forwarded  into  the
neural  network  model.  Furthermore,  each  augmentation
method had a random probability of 15% to be applied on
the current image with random intensity or parameters (e.g.
random  angle  for  rotation).  Through  this  technique,  the
probability that the model encounters the exact same image
twice during the training process decreases significantly.
3.4 Patchwise Analysis and Batch Generation
In  image  analysis  there  are  two  popular  methods:  The
analysis of full images or patchwise by slicing the volume
into smaller cuboid patches [11]. We selected the patchwise
approach in order to exploit random cropping for the fitting
process. Through random forwarding only a single cropped
patch from the image to the fitting process, another type of
data  augmentation  is  induced,  and  the  risk  of  overfitting
additionally  decreased.  Furthermore,  full  image  analysis
requires  unnecessary  resolution  reduction  of  the  3D
volumes  in  order  to  handle  the  enormous  GPU memory
requirements.  By slicing the volumes into patches with a
shape  of  160x160x80,  we  were  able  to  utilize  high-
resolution data.
For inference, the volumes were sliced into patches
according to a grid. Between the patches, we introduced an
overlap  of  half  the  patch  size  (80x80x40)  to  increase
prediction performance. After the inference of each patch,
they  were  reassembled  into  the  original  volume  shape,
whereas overlapping regions were averaged.
The complete batch generation process, including
the patch cropping and data augmentation for training, was
implemented  as  on-the-fly.  This  means  that  batches  are
created during the fitting process instead beforehand. This
allowed the creation of novel and unique images by the data
augmentation  in  each  iteration.  For  training,  we  used  a
batch size of 2.
3.5 Neural Network Model
The neural  network architecture and its  hyper parameters
are one of the key parts in a medical image segmentation
pipeline. In this work, we implemented the standard 3D U-
Net as architecture in order to avoid unnecessary parameter
increase  by  more  complex  architectures  like  the  residual
variant  of  the  3D  U-Net  [23,41,42].  Upsampling  was
achieved via transposed convolution and downsampling via
maximum pooling. The architecture used 32 feature maps at
its highest resolution and 512 at its lowest. All convolutions
were  applied  with  a  kernel  size  of  3x3x3  in  a  stride  of
1x1x1,  except  for  up-  and  downsampling  convolutions
which were applied with a kernel size of 2x2x2 in a stride
of 2x2x2.
In medical image segmentation, it is common that
semantic  annotation  includes  a  strong  bias  in  class
distribution  towards  the  background  class.  Our  dataset
revealed a class distribution of 89% for background, 9% for
lungs  and  1%  for  infection.  In  order  to  compensate  this
class  bias,  we  utilized  the  sum  of  the  Tversky  index
Figure 3: The architecture of the standard 3D U-Net. The network takes a 3D patch (cuboid) and outputs the segmentation of lungs and
infected regions by COVID-19.  Skip connections  were  implemented with concatenation  layers.  Conv:  Convultional  layer;  ReLU:
Rectified linear unit layer; BN: Batch normalization. 
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[43] and the categorical cross-entropy as loss function for
model fitting (1). 
Ltotal = LTversky + LCCE (1)
LTversky = N−∑
c=1
N TPc
TPc + α⋅FNc + β⋅FPc
(2)
LCCE = −∑
c=1
N
yo , c log( po , c) (3)
We implemented a multi-class adaptation for the Tversky
index  (2),  which  is  an  asymmetric  similarity  index  to
measure  the  overlap  of  the  segmented  region  with  the
ground truth. It allows for flexibility in balancing the false
positive rate (FP) and false negative (FN) rate. The cross-
entropy (3) is a commonly used loss function in machine
learning  and  calculates  the  total  entropy  between  the
predicted and true distribution. The multi-class adaptation
for  multiple  categories  (categorical  cross-entropy)  is
represented through the sum of the binary cross-entropy for
each class c, whereas yo,c is the binary indicator whether the
class label  c is the correct classification for observation  o.
The variable po,c is the predicted probability that observation
o is of class c.
For model fitting, an Adam optimization was used
with the  initial  weight  decay  of  1e-3  [44].  We utilized  a
dynamic learning rate which reduced the learning rate by a
factor of 0.1 in case the training loss did not decrease for 15
epochs. The minimal learning rate was set to 1e-5. In order
to further  reduce the risk of  overfitting, we exploited the
early stopping technique for training, in which the training
process  stopped  without  a  fitting  loss  decrease  after  100
epochs.  The  neural  network  model  was  trained  for  a
maximum of 1000 epochs.  Instead of the common epoch
definition as a single iteration over the dataset, we defined
an epoch as  the  iteration over 150 training batches.  This
allowed  for  an  improved  fitting  process  for  randomly
generated batches in which the dataset acts as a variation
database.  According  to  our  available  GPU  VRAM,  we
selected a batch size of 2.
3.6 Evaluation Metrics
During the fitting process, we computed the segmentation
performance for each epoch on randomly cropped and data
augmented  patches  from  the  validation  dataset.  This
allowed for an evaluation of the overfitting on the training
data.
After  the training, we used three widely popular
evaluation  metrics  in  the  community  for  medical  image
analysis  to  do the inference performance measurement  in
order  to  measure  the  segmentation  overlap  between
prediction and ground truth. The Dice similarity coefficient,
defined in (4), is the most widespread metric in computer
vision. In contrast, the sensitivity (5) and specificity (6) are
one  of  the  most  popular  metrics  in  medical  fields.  All
metrics are based on the confusion matrix, where  TP,  FP,
TN and  FN represent the true positive, false positive, true
negative and false negative rate, respectively.
DSC = 2⋅TP
2⋅TP + FP + FN (4)
Sensitivity = TP
TP + FN (5)
Specificity = TN
TN + FP (6)
We calculated the evaluation metrics for each fold
in  the  cross-validation,  and  thus,  for  all  samples  in  our
dataset. The two lung classes (lung left and lung right) were
averaged  by  mean  into  a  single  class  (lungs)  during  the
evaluation.
3.7 Code Reproducibility
In order to ensure full reproducibility and to create a base
for  further  research,  the  complete  code  of  this  project,
including  extensive  documentation,  is  available  in  the
following Git repository:
https://github.com/frankkramer-lab/covid19.MIScnn
4. RESULTS & DISCUSSION
The sequential training of the complete cross-validation on
a  single  GPU  took  around  130  hours.  All  folds  did  not
require the entire 1000 epochs for training and instead were
early stopped after an average of 312 epochs.
Through validation monitoring during the training,
no  overfitting  was  observed.  The  training  and  validation
loss function revealed no significant distinction from each
other, which can be seen in figure 4. During the fitting, the
performance settled down at a loss of around 0.383 which is
a  generalized  DSC  (average  of  all  class-wise  DSCs)  of
around  0.919.  Because  of  this  robust  training  process
without any signs of overfitting, we concluded that fitting
on  randomly  generated  patches  via  extensive  data
augmentation and random cropping from a variant database,
is highly efficient for limited imaging data.
After the training, the inference revealed a strong
segmentation  performance  for  lungs  and  COVID-19
infected regions, which is illustrated in figure 6. Overall, the
cross-validation models  achieved a DSC of around 0.956
for lung and 0.761 for COVID-19 infection segmentation.
Furthermore,  the  models  achieved  a  sensitivity  and
specificity of 0.956 and 0.998 for lungs, as well as 0.730
and 0.999 for  infection, respectively.  More details  on the
inference performance is listed in table  1. From a medical
perspective,  detection  of  COVID-19  infection  is  a
challenging  task  and  one  of  the  reasons  for  the  weaker
segmentation accuracy in contrast to the lung segmentation.
The reason for this is the variety of GGO and pulmonary
consolidation morphology. Nevertheless, our medical image
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segmentation pipeline allowed fitting a model which is able
to  segment  COVID-19  infection  with  state-of-the-art
accuracy  that  is  comparable  to  models  trained  on  large
datasets.
For further evaluation, we compared our pipeline
to  other  available  COVID-19  segmentation  approaches
based  on  CT scans.  The  authors  (Ma  et  al.),  who  also
provided the dataset we used for our analysis, implemented
a 3D U-Net approach as a baseline for benchmarking [16].
They were able to achieve a DSC of 0.70355 and 0.6078 for
lungs  and  COVID-19  infection,  respectively.  With  our
model,  we  were  able  to  outperform  this  baseline.  It  is
important to mention that we trained with a cross-validation
distribution of 80% training and 20% testing, whereas they
used  the  inverted  distribution  (20%  training  and  80%
testing).  Another  approach  from  Yan  et  al. developed  a
novel  neural  network  architecture  (COVID-SegNet)
specifically designed for COVID-19 infection segmentation
with limited data [29]. The authors tested their architecture
on a limited dataset consisting of ten COVID-19 cases from
Brainlab  Co.  Ltd  (Germany)  and  were  able  to  achieve  a
DSC  of  0.987  and  0.726  for  lungs  and  infection,
respectively.  Hence,  COVID-SegNet  as  well  as  our
approach achieved similar results. This raises the question,
if  it  is  possible  to  further  increase  our  performance  by
switching  from the  standard  U-Net  of  our  pipeline  to  an
architecture specifically designed for COVID-19 infection
segmentation  like  COVID-SegNet.  Further  approaches,
with the aim to utilize specifically designed architectures,
were Inf-Net (Fan et al.) and MiniSeg (Qiu et al.) [34,35].
Both  were  trained  on  2D  CT  scans  and  achieved  for
COVID-19  infection  segmentation  DSCs  of  0.764  and
0.773, respectively. Although diverse datasets were used for
training, which leads to incomparability of the results, it is
highly impressive that they achieved similar performance as
approaches  based  on  3D  imaging  data.  The  3D
transformation of these architectures and the integration into
our pipeline would be an interesting experiment to evaluate
improvement possibilities. 
However, it is important to note that the majority
of  current  segmentation  approaches  in  research  are  not
suited for clinical usage. The bias of current models is that
they  are  only  trained  with  COVID-19  related  images.
Therefore,  it  is  not  certain  how  good  the  models  can
differentiate  between  COVID-19  lesions  and  other
pneumonia,  or  entirely  unrelated  medical  conditions  like
cancer. Furthermore, identical to COVID-19 classification,
the  models  reveal  huge  differences  depending  on  which
dataset they were trained on. Segmentation models purely
based on COVID-19 scans are often not able to segment
accurately in the presence of other medical conditions [16].
Additionally,  there  is  a  high  potential  for  false  positive
segmentation of pneumonia lesions that are not caused by
COVID-19. This demonstrates that these models could be
biased  and  are  not  suitable  for  COVID-19  screening.
Nevertheless,  current  infection  segmentation  models  are
Table  1: Achieved results showing the median Dice similarity coefficient
(DSC), the sensitivity (Sens) and specificity (Spec) on Lung and COVID-
19 infection segmentation for each CV fold and the global average (AVG).
Lungs COVID-19
Fold DSC Sens. Spec. DSC Sens. Spec.
1 0.907 0.913 0.995 0.556 0.447 0.999
2 0.977 0.979 0.998 0.801 0.875 0.999
3 0.952 0.945 0.999 0.829 0.796 0.999
4 0.979 0.975 0.999 0.853 0.836 0.999
5 0.967 0.967 0.999 0.765 0.697 0.999
AVG 0.956 0.956 0.998 0.761 0.730 0.999
Figure  4: Loss course during the training process  for training (red) and
validation  (cyan)  data.  The  lines  were  computed  via  Gaussian  Process
Regression and represent the average loss across all folds. The gray areas
around the lines represents the confidence intervals. Figure 5: Box plots showing the result distribution from the 5-fold cross-
validation on Lung and COVID-19 infection segmentation. 
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already highly accurate for confirmed COVID-19 imaging.
This offers the opportunity for quantitative assessment and
disease monitoring as applications in clinical studies. 
Despite that our model and those of others, which
are  based  on  limited  data,  are  capable  for  accurate
segmentation,  it  is  essential  to  discuss  their  robustness.
Currently, there are no large as well as annotated imaging
datasets  available  for  COVID-19  segmentation  [16].
Existing small datasets may have incomplete and inaccurate
labels  which results  in challenging handicaps for  models.
More imaging data with more variance (different COVID-
19  states,  other  pneumonia,  etc.)  need  to  be  collected,
annotated and published for researchers. Similar to  Ma et
al.,  community  accepted  benchmark  datasets  have  to  be
established in  order  to  fully  ensure robustness  as  well  as
comparability of models [16,36].
5. CONCLUSION
In this paper, we developed and evaluated an approach for
automated segmentation of COVID-19 infected regions in
CT volumes. Our method focuses on on-the-fly generation
of  unique  and  random  image  patches  for  training  by
performing  several  preprocessing  methods  and  exploiting
extensive data augmentation. Thus, it is possible to handle
limited dataset sizes which act as variant database. Instead
of  novel  and  complex  neural  network  architectures,  we
utilized the standard 3D U-Net. We proved that our medical
image  segmentation  pipeline  is  able  to  successfully  train
accurate and robust models without overfitting on limited
data.  Furthermore,  we  were  able  to  outperform  current
state-of-the-art semantic segmentation approaches for lungs
and  COVID-19  infected  regions.  Our  work  has  great
potential to be applied as a clinical decision support system
for  COVID-19  quantitative  assessment  and  disease
monitoring in a clinical environment. Nevertheless, further
research is needed on COVID-19 semantic segmentation in
clinical  studies  for  evaluating  clinical  performance  and
robustness. 
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